Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Adherence to Antiretroviral Therapy Among HIV Patients in India: A Systematic Review and Meta-analysis.

Chakraborty A, Hershow RC, Qato DM, Stayner L, Dworkin MS.

AIDS Behav. 2020 Jan 13. doi: 10.1007/s10461-020-02779-4. [Epub ahead of print]

PMID:
31933019
2.

Effects of vitamin K1 treatment on plasma concentrations of long-acting anticoagulant rodenticide enantiomers following inhalation of contaminated synthetic cannabinoids.

Feinstein DL, Nosal DG, Ramanathan S, Zhou J, Chen L, Hershow RC, van Breemen RB, Wright E, Hafner JW, Rubinstein I.

Clin Toxicol (Phila). 2019 Nov 18:1-9. doi: 10.1080/15563650.2019.1687903. [Epub ahead of print]

PMID:
31736367
3.

Antiretroviral therapy adherence among treatment-naive HIV-infected patients.

Chakraborty A, Qato DM, Awadalla SS, Hershow RC, Dworkin MS.

AIDS. 2020 Jan 1;34(1):127-137. doi: 10.1097/QAD.0000000000002384.

PMID:
31567165
4.

Assessment of the Appropriateness of Antibiotic Prescriptions for Infection Prophylaxis Before Dental Procedures, 2011 to 2015.

Suda KJ, Calip GS, Zhou J, Rowan S, Gross AE, Hershow RC, Perez RI, McGregor JC, Evans CT.

JAMA Netw Open. 2019 May 3;2(5):e193909. doi: 10.1001/jamanetworkopen.2019.3909.

5.

Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients?

Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.

Drugs R D. 2019 Mar;19(1):67-71. doi: 10.1007/s40268-019-0261-4.

6.

Virological Non-suppression and Its Correlates Among Adolescents and Young People Living with HIV in Southern Malawi.

Umar E, Levy JA, Bailey RC, Donenberg G, Hershow RC, Mackesy-Amiti ME.

AIDS Behav. 2019 Feb;23(2):513-522. doi: 10.1007/s10461-018-2255-6.

PMID:
30132172
7.

Evaluation of the effectiveness of a latrine intervention in the reduction of childhood diarrhoeal health in Nyando District, Kisumu County, Kenya.

Babb C, Makotsi N, Heimler I, Bailey RC, Hershow RC, Masanga P, Mehta SD.

Epidemiol Infect. 2018 Jul;146(9):1079-1088. doi: 10.1017/S0950268818000924. Epub 2018 May 10.

PMID:
29745351
8.

Treatment for long acting anticoagulant rodenticide poisoning - beyond INR monitoring?

Rubinstein I, Weinberg G, van Breemen R, Hershow RC, Feinstein DL.

Toxicol Commun. 2018;2(1):59-61. doi: 10.1080/24734306.2018.1500152. Epub 2018 Aug 13.

9.

Measurement of Neighborhood Context in an Urban Cohort of HIV-infected or at risk Low-Income Women.

Burke-Miller JK, Weber K, Cohn SE, Hershow RC, Sha B, French AL, Cohen MH.

J Poverty. 2017;21(1):80-96. doi: 10.1080/10875549.2016.1262933. Epub 2016 Dec 9.

10.

Prevalence and Predictors of Hospitalizations Among HIV-Infected and At-Risk HIV-Uninfected Women.

Hotton AL, Weber KM, Hershow RC, Anastos K, Bacchetti P, Golub ET, Gustafson D, Levine AM, Young M, Cohen MH.

J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):e27-e35. doi: 10.1097/QAI.0000000000001278.

11.

Assessment of an Aggregate-Level Hand Hygiene Monitoring Technology for Measuring Hand Hygiene Performance Among Healthcare Personnel.

Limper HM, Slawsky L, Garcia-Houchins S, Mehta S, Hershow RC, Landon E.

Infect Control Hosp Epidemiol. 2017 Mar;38(3):348-352. doi: 10.1017/ice.2016.298. Epub 2016 Dec 19.

PMID:
27989240
12.

Awareness of Hepatitis C Virus Seropositivity and Chronic Infection in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Kuniholm MH, Jung M, Del Amo J, Talavera GA, Thyagarajan B, Hershow RC, Damas OM, Kaplan RC.

J Immigr Minor Health. 2016 Dec;18(6):1257-1265.

13.

A Validation Protocol: Assessing the Accuracy of Hand Hygiene Monitoring Technology.

Limper HM, Garcia-Houchins S, Slawsky L, Hershow RC, Landon E.

Infect Control Hosp Epidemiol. 2016 Aug;37(8):1002-4. doi: 10.1017/ice.2016.133. No abstract available.

PMID:
27448062
14.

Neighborhood community characteristics associated with HIV disease outcomes in a cohort of urban women living with HIV.

Burke-Miller JK, Weber K, Cohn SE, Hershow RC, Sha BE, French AL, Cohen MH.

AIDS Care. 2016 Oct;28(10):1274-9. doi: 10.1080/09540121.2016.1173642. Epub 2016 Apr 21.

15.

Relationship between Body Mass Index and Mortality in HIV-Infected HAART Users in the Women's Interagency HIV Study.

Sharma A, Hoover DR, Shi Q, Gustafson D, Plankey MW, Hershow RC, Tien PC, Golub ET, Anastos K.

PLoS One. 2015 Dec 23;10(12):e0143740. doi: 10.1371/journal.pone.0143740. eCollection 2015.

16.

Gender-Related Risk Factors Improve Mortality Predictive Ability of VACS Index Among HIV-Infected Women.

Cohen MH, Hotton AL, Hershow RC, Levine A, Bacchetti P, Golub ET, Anastos K, Young M, Gustafson D, Weber KM.

J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):538-44. doi: 10.1097/QAI.0000000000000795.

17.

A randomized trial comparing standard outcomes in two treatment models for substance users with tuberculosis.

Ricks PM, Hershow RC, Rahimian A, Huo D, Johnson W, Prachand N, Jimenez A, Wiebel W, Paul W.

Int J Tuberc Lung Dis. 2015 Mar;19(3):326-32. doi: 10.5588/ijtld.14.0471.

PMID:
25686142
18.

Changes in Body Mass Index Following HAART Initiation among HIV-Infected Women in the Women's Interagency HIV Study.

Sharma A, Bynum SA, Schneider MF, Cox C, Tien PC, Hershow RC, Gustafson D, Plankey MW.

J AIDS Clin Res. 2014;5. pii: 1000323.

19.

Prevalence of drug resistant tuberculosis among patients at high-risk for Hiv attending outpatient clinics in Delhi, India.

Magee MJ, Blumberg HM, Broz D, Furner SE, Samson L, Singh S, Hershow RC.

Southeast Asian J Trop Med Public Health. 2012 Mar;43(2):354-63.

PMID:
23082587
20.

Enteric pathogens in stool samples of Chicago-area water recreators with new-onset gastrointestinal symptoms.

Dorevitch S, Dworkin MS, Deflorio SA, Janda WM, Wuellner J, Hershow RC.

Water Res. 2012 Oct 15;46(16):4961-72. doi: 10.1016/j.watres.2012.06.030. Epub 2012 Jul 6.

PMID:
22819874
21.

Commentary on Thorne et al. (2012): HIV prevention and treatment in female injection drug users--a work in progress.

Hershow RC.

Addiction. 2012 Jan;107(1):129-30. doi: 10.1111/j.1360-0443.2011.03708.x. No abstract available.

PMID:
22151320
22.

Chronic hepatitis C virus infection and increases in viral load in a prospective cohort of young, HIV-uninfected injection drug users.

Boodram B, Hershow RC, Cotler SJ, Ouellet LJ.

Drug Alcohol Depend. 2011 Dec 15;119(3):166-71. doi: 10.1016/j.drugalcdep.2011.06.005. Epub 2011 Jul 2.

23.

Underreporting of blood and body fluid exposures among health care students and trainees in the acute care setting: a 2007 survey.

Kessler CS, McGuinn M, Spec A, Christensen J, Baragi R, Hershow RC.

Am J Infect Control. 2011 Mar;39(2):129-34. doi: 10.1016/j.ajic.2010.06.023. Review.

PMID:
21356431
24.

GB virus C infection among young, HIV-negative injection drug users with and without hepatitis C virus infection.

Boodram B, Hershow RC, Klinzman D, Stapleton JT.

J Viral Hepat. 2011 Apr;18(4):e153-9. doi: 10.1111/j.1365-2893.2010.01350.x.

25.

Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals.

Ouyang DW, Brogly SB, Lu M, Shapiro DE, Hershow RC, French AL, Leighty RM, Thompson B, Tuomala RE.

AIDS. 2010 Jan 2;24(1):109-14. doi: 10.1097/QAD.0b013e3283323941.

26.

Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women's Interagency HIV Study.

Boodram B, Plankey MW, Cox C, Tien PC, Cohen MH, Anastos K, Karim R, Hyman C, Hershow RC.

AIDS Patient Care STDS. 2009 Dec;23(12):1009-16. doi: 10.1089/apc.2009.0175.

27.

Predictors and outcomes of antibiotic adequacy for bloodstream infections in veterans with spinal cord injury.

Evans CT, Burns SP, Chin A, Weaver FM, Hershow RC.

Arch Phys Med Rehabil. 2009 Aug;90(8):1364-70. doi: 10.1016/j.apmr.2009.02.012.

PMID:
19651270
28.

Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure.

Ouyang DW, Shapiro DE, Lu M, Brogly SB, French AL, Leighty RM, Thompson B, Tuomala RE, Hershow RC.

AIDS. 2009 Nov 27;23(18):2425-30. doi: 10.1097/QAD.0b013e32832e34b1.

29.

Escherichia coli and Klebsiella pneumoniae carbapenemase in long-term care facility, Illinois, USA.

McGuinn M, Hershow RC, Janda WM.

Emerg Infect Dis. 2009 Jun;15(6):988-9. doi: 10.3201/eid1506.081735. No abstract available.

30.

Bloodstream infections and setting of onset in persons with spinal cord injury and disorder.

Evans CT, Hershow RC, Chin A, Foulis PR, Burns SP, Weaver FM.

Spinal Cord. 2009 Aug;47(8):610-5. doi: 10.1038/sc.2009.2. Epub 2009 Feb 24.

PMID:
19238165
31.

Lessons learned from Chicago's emergency response to mass evacuations caused by Hurricane Katrina.

Broz D, Levin EC, Mucha AP, Pelzel D, Wong W, Persky VW, Hershow RC.

Am J Public Health. 2009 Aug;99(8):1496-504. doi: 10.2105/AJPH.2007.126680. Epub 2009 Feb 5.

32.

Maternal neutralizing antibody and transmission of hepatitis C virus to infants.

Dowd KA, Hershow RC, Yawetz S, Larussa P, Diaz C, Landesman SH, Paul ME, Read JS, Lu M, Thomas DL, Netski DM, Ray SC.

J Infect Dis. 2008 Dec 1;198(11):1651-5. doi: 10.1086/593067.

33.

One medicine, one university: the DVM/MPH program at the University of Illinois.

Herrmann JA, Hershow RC.

J Vet Med Educ. 2008 Summer;35(2):194-8. doi: 10.3138/jvme.35.2.194.

PMID:
18723802
34.

Analysis of standard methods for diagnosing vaginitis: HIV infection does not complicate the diagnosis of vaginitis.

Sha BE, Gawel SH, Hershow RC, Passaro D, Augenbraun M, Darragh TM, Stek A, Golub ET, Mph LC, Moxley MD, Weber KM, Watts DH.

J Low Genit Tract Dis. 2007 Oct;11(4):240-50.

PMID:
17917568
36.

Colonization or infection with multidrug-resistant Acinetobacter baumannii may be an independent risk factor for increased mortality.

Gkrania-Klotsas E, Hershow RC.

Clin Infect Dis. 2006 Nov 1;43(9):1224-5. No abstract available.

PMID:
17029151
37.

Mode of delivery and postpartum HIV-1 disease progression: the Women and Infants Transmission Study.

Navas-Nacher EL, Read JS, Leighty RM, Tuomala RE, Zorrilla CD, Landesman S, Rosenblatt H, Hershow RC; Women and Infants Transmission Study Group.

AIDS. 2006 Feb 14;20(3):429-36.

PMID:
16439877
38.

Drug use and HIV risk practices of secondary and primary needle exchange users.

Huo D, Bailey SL, Hershow RC, Ouellet L.

AIDS Educ Prev. 2005 Apr;17(2):170-84.

PMID:
15899754
39.

The relationship between vaccine refusal and self-report of atopic disease in children.

Enriquez R, Addington W, Davis F, Freels S, Park CL, Hershow RC, Persky V.

J Allergy Clin Immunol. 2005 Apr;115(4):737-44.

PMID:
15805992
40.

Peering into the future of American longevity.

Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Brody J, Carnes BA, Hayflick L, Butler RN, Allison DB, Ludwig DS.

Discov Med. 2005 Apr;5(26):130-4.

41.

A potential decline in life expectancy in the United States in the 21st century.

Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, Hayflick L, Butler RN, Allison DB, Ludwig DS.

N Engl J Med. 2005 Mar 17;352(11):1138-45.

42.

Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.

Hershow RC, O'Driscoll PT, Handelsman E, Pitt J, Hillyer G, Serchuck L, Lu M, Chen KT, Yawetz S, Pacheco S, Davenny K, Adeniyi-Jones S, Thomas DL.

Clin Infect Dis. 2005 Mar 15;40(6):859-67. Epub 2005 Feb 18.

PMID:
15736020
43.

Effect of hard-drug use on CD4 cell percentage, HIV RNA level, and progression to AIDS-defining class C events among HIV-infected women.

Thorpe LE, Frederick M, Pitt J, Cheng I, Watts DH, Buschur S, Green K, Zorrilla C, Landesman SH, Hershow RC.

J Acquir Immune Defic Syndr. 2004 Nov 1;37(3):1423-30.

PMID:
15483472
44.

Heroin insufflation as a trigger for patients with life-threatening asthma.

Krantz AJ, Hershow RC, Prachand N, Hayden DM, Franklin C, Hryhorczuk DO.

Chest. 2003 Feb;123(2):510-7.

PMID:
12576374
45.

Risk factors for Kaposi's sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA.

Goedert JJ, Charurat M, Blattner WA, Hershow RC, Pitt J, Diaz C, Mofenson LM, Green K, Minkoff H, Paul ME, Thomas DL, Whitby D; Women and Infants Transmission Study.

AIDS. 2003 Feb 14;17(3):425-33.

PMID:
12556697
46.

The effect of renal dysfunction on antimicrobial use measurements.

Zagorski BM, Trick WE, Schwartz DN, Wisniewski MF, Hershow RC, Fridkin SK, Weinstein RA.

Clin Infect Dis. 2002 Dec 15;35(12):1491-7. Epub 2002 Dec 2.

PMID:
12471568
47.

Effects of human T-lymphotropic virus type II on human immunodeficiency virus type 1 phenotypic evolution.

Guenthner PC, Hershow RC, Lal RB, Dezzutti CS.

Arch Virol. 2001 Aug;146(8):1617-22.

PMID:
11676422
48.

The natural history of hepatitis D virus infection in Illinois state facilities for the developmentally disabled.

Abiad H, Ramani R, Currie JB, Hershow RC.

Am J Gastroenterol. 2001 Feb;96(2):534-40.

PMID:
11232702
49.

Body composition in HIV-infected women.

Swanson B, Hershow RC, Sha BE, Benson CA, Cohen M, Gunfeld C.

Nutrition. 2000 Nov-Dec;16(11-12):1064-8.

PMID:
11118826
50.

The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program.

Brambilla D, Reichelderfer PS, Bremer JW, Shapiro DE, Hershow RC, Katzenstein DA, Hammer SM, Jackson B, Collier AC, Sperling RS, Fowler MG, Coombs RW.

AIDS. 1999 Nov 12;13(16):2269-79.

PMID:
10563712

Supplemental Content

Loading ...
Support Center